Nyxoah
Scott Holstine is an experienced executive in the medical and commercial sectors, currently serving as the Chief Commercial Officer at Nyxoah. Previously, Scott founded and held the position of Non-Executive Director at Ibex Passage. Additionally, Scott has held significant roles at Teleflex as President, Amplifon as Senior Vice President and General Manager, and Nuvectra as Vice President of US Sales.
This person is not in any teams
This person is not in any offices
Nyxoah
Nyxoah is a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy.